St John’s Innovation Centre-based Crayfish.io is offering free English-Chinese machine translations to all medical and life science companies working to halt the Coronavirus crisis.
The go-to platform and full-service provider, dedicated to helping UK companies better engage with the Chinese market, is offering the free translation in a bid to assist medical R&D and facilitate cross-border collaborations in this important fight.
The translation platform – developed by Cloudtranslate, one of Crayfish’s strategic partners in China – uses state-of-the-art AI technology to provide machine translation solutions for scientific, medical and health industry users worldwide.
Companies working in medical and life science sectors specifically to combat Coronavirus can obtain free access to the translation platform by contacting email@example.com
Ting Zhang, Founder & CEO of Crayfish.io, said: “We are offering the use of this dedicated medical translation platform free of charge to the specified companies for the duration of the epidemic – and are also available to help and advise businesses affected by the situation and going through difficult scenarios.
“The Crayfish.io team has also been assisting the local Chinese community’s fund-raising efforts to ship medical supplies to hospitals in Wuhan and other cities in China. Our thoughts are firmly with all those affected by this terrible situation.”
For more information please visit www.crayfish.io
Crayfish.io is the go-to platform dedicated to enabling better engagement with China powered by technology. With an extensive network of Chinese experts, Crayfish.io provides a range of services to facilitate cross-border collaborations. The Crayfish.io Accelerator is the UK’s first fully funded initiative to get tech startups China-ready. www.crayfish.io
Terms and conditions of free machine translations for the duration of the Coronavirus crisis:
1. Crayfish.io is not to be held responsible for the quality of the translation from the free machine translation engine
2. Only companies in life science and medical sector are eligible for this initiative, excluding those that provide translation as a service
3. The free access will be available until further notice